Heat-resistant agarase and monosaccharide production method using same

Abstract

The present invention relates to a heat-resistant agarase and a monosaccharide production method using same. More particularly, in the present invention, a heat-resistant agarase may be used to produce galactose and 3,6-anhydro-L-galactose at high yield by efficiently breaking down agarose or agar without a chemical pretreatment, a neutralization process, or an agarotriose hydrolase treatment process.

Claims

1. A method for producing galactose or 3,6-anhydro-L-galactose, comprising reacting an agarase comprising the amino acid sequence of SEQ ID NO: 1 with not-pretreated agarose or agar as a substrate under a temperature range of 50 to 60 C. to produce neoagarotetraose or neoagarohexaose as a reaction product, reacting an agarase comprising the amino acid sequence of SEQ ID NO: 3 with the reaction product to produce neoagarobiose, and reacting an -neoagarobiose hydrolase comprising the amino acid sequence of SEQ ID NO: 4 with neoagarobiose to produce galactose or 3,6-anhydro-L-galactose.

2. The method of claim 1, wherein the reaction of the agarase with agarose or agar is performed within a temperature range of 55 C., under a condition of 0 to 300 rpm, and at a pH of 5 to 9 for 30 minutes to 7 days.

3. The method of claim 1, wherein the reaction by the agarase and or the -neoagarobiose hydrolase is performed within a temperature range of 20 to 40 C. and under a condition of 0 to 200 rpm for 30 minutes to 7 days.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) FIG. 1 is a sol-gel phase transition analysis result of agarose, which is confirmed while 1% agarose is cooled down.

(2) FIG. 2 is an SDS-PAGE result in which Aga16B is overexpressed and purified, Line M indicates a protein ladder, Line 1 indicates a crude protein, Line 2 indicates a sample circulating a His-Trap column and exiting the His-Trap column, Line 3 indicates a sample flowing in a column with an EQ buffer, and Lines 4, 5, and 6 indicate purified Aga16B.

(3) FIG. 3a is a result of measuring an optimal pH of Aga16B, and FIG. 3b is a result of measuring an optimal reaction temperature of Aga16B.

(4) FIG. 4 is a result of an experiment on stability of Aga16B at various temperatures.

(5) FIG. 5 is a result illustrating an effect of an Aga16B protein-loading amount according to initial rate.

(6) FIG. 6a is a TLC analysis result of Aga16B reaction products, and

(7) FIG. 6b is an HPLC analysis result of Aga16B reaction products.

(8) FIG. 7a illustrates a MALDI-TOF/TOF MS confirmation result of reaction products of Aga16B, FIG. 7b illustrates a tandem MS analysis result of DP4 which is a reaction product of Aga16B, and FIG. 7c illustrates a tandem MS analysis result of DP6 which is a reaction product of Aga16B.

(9) FIG. 8 is a result which observes the degree to which agarose is liquefied by Aga16B.

(10) FIG. 9a is a TLC analysis result illustrating the enzymatic saccharification of agarose by Aga16B, Aga50D, and NABH, Processing step No. 1 is a 5% agarose substrate, Processing step No. 2 is a reaction product after a reaction of agarose with Aga16B, Processing step No. 3 is a reaction product of Aga15D with respect to Aga16B reaction products, and Processing step No. 4 is a reaction product of NABH with respect to Aga15D reaction products.

(11) FIG. 9b is an HPLC analysis result illustrating the enzymatic saccharification of agarose by Aga16B, Aga50D, and NABH.

(12) FIG. 10 is a schematic view illustrating the saccharification process of agarose by Aga16B, Aga50D, and NABH according to the related art and the present invention.

DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

(13) Hereinafter, the composition of the present invention will be described in detail.

(14) The present invention relates to a composition for producing galactose or 3,6-anhydro-L-galactose, comprising: a heat-resistant agarase including an amino acid sequence of SEQ ID NO: 1; an exo-type agarase; and an -neoagarobiose hydrolase.

(15) Further, the present invention provides a method for producing galactose or 3,6-anhydro-L-galactose, the method comprising reacting agarose or agar as a substrate with the aforementioned composition for producing galactose or 3,6-anhydro-L-galactose.

(16) The present inventors have developed a processing method for producing 3,6-anhydro-L-galactose and D-galactose at high yield by applying a heat-resistant agarase Aga16B to a process to omit a chemical treatment process and allowing three enzymes (Aga16B, Aga50D, and NABH) to sequentially react with an agarose substrate to break down agarose through only enzymatic saccharification in order to improve a pretreatment method using acetic acid and a hot water pretreatment method using a Tris-HCl buffer (pH 7.4), which are known in the related art, and furthermore, solve a problem in that salts are generated during the neutralization process accompanying these pretreatment methods and a problem in that during the treatment process at a high temperature, 3,6-anhydro-L-galactose is excessively broken down into 5-HMF, and as a result, the saccharification yield is lowered.

(17) Accordingly, galactose or 3,6-anhydro-L-galactose according to the present invention may be produced by reacting a heat-resistant agarase with agarose or agar, and then reacting reaction products obtained therefrom with an exo-type agarase and an -neoagarobiose hydrolase.

(18) A method for producing 3,6-anhydro-L-galactose and D-galactose from agarose or agar by using a heat-resistant endo-type agarase, an exo-type agarase, and an -neoagarobiose hydrolase without a weak acid or a buffer pretreatment process according to the present invention has the following benefits (see FIG. 10). 1) There is an effect of reducing costs because expensive acetic acid is not used. In addition, because 3,6-anhydro-L-galactose in the final breakdown products is a material which may also be used as a cosmetic functional material, the fact that acetic acid which induces an unpleasant odor is not used is one of the greatest advantages. 2) Salts such as sodium acetate produced through the neutralization process are not formed. 3) Since excessively broken down products such as 5-HMF are not produced, the yield of producing monosaccharides may be increased. 4) Since the existing chemical treatment process requires an apparatus such as a microwave, but an enzymatic process is carried out at a low temperature, a high-temperature adjusting apparatus is not required, so that there is a benefit in the scale-up. 5) When three types of enzyme groups are used, agarotriose is not produced as a breakdown product, so that an agarotriose hydrolase does not need to be used.

(19) The heat-resistant agarase is an endo-type agarase, and the sol state of agarose in water in the enzymatic liquefaction of agarose may be more accessible to the enzyme than the gel state of agarose, so that as a result of evaluating a heat-resistant endo-type -agarase, Aga16B as an agarose liquefaction enzyme, Aga16B maintains high thermal stability up to 50 C. exceeding a sol-gel transition temperature (35 C.) of 1% (v/v) agarose in water, and more specifically, exhibits an optimal activity at about 55 C., and exhibits a breakdown activity of agarose or agar from room temperature to 60 C., so that Aga16B is characterized by being suitable for the enzymatic liquefaction of agarose at a relatively high temperature. Accordingly, Aga16B is characterized by being able to exhibit an activity within a temperature range in which agarose or agar is maintained in a liquid state, that is, at about 35 C. or more.

(20) It was confirmed that the heat-resistant agarase uses agarose or agar as a substrate, and the enzymatic reaction products are neoagarotetraose and neoagarohexaose, which have a degree of polymerization (DP) of 4 and 6, respectively.

(21) When an exo-type agarase and an -neoagarobiose hydrolase, which are exo-type agarases, are sequentially treated, the heat-resistant agarase may exhibit a saccharification yield which is improved as compared to a saccharification yield obtained through chemical pretreatment in the related art. According to a specific exemplary embodiment, a saccharification yield increased by about 1.6 times (72.5% of theoretical maximum) as compared to the existing buffer pretreatment was obtained.

(22) The heat-resistant agarase may be transcribed and translated through not only a region before and after a coding region of the enzyme, but also a DNA segment associated with the production of a polypeptide including an intervening sequence between individual coding segments, that is, a coding gene. For example, the heat-resistant agarase may be transcribed and translated from the sequence set forth in SEQ ID NO: 2, but is not particularly limited thereto. Further, a protein having a hydrolytic activity into the neoagarotetraose or the neoagarohexaose as a variant protein with one or more substitutions, deletions, translocations, additions, and the like of the enzyme is also included in the scope of rights of the enzyme of the present invention, and preferably, includes an amino acid sequence having a sequence identity of 80% or more, 85% or more, 90% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, and 99% or more with the amino acid sequence set forth in SEQ ID NO: 1.

(23) The heat-resistant agarase may be derived from Saccharophagus degradans 2-40.sup.T, but is not particularly limited thereto.

(24) The heat-resistant agarase may be separated and purified from a supernatant of the Saccharophagus degradans 2-40.sup.T culture, and may be produced and separated by a strain other than the Saccharophagus degradans 2-40.sup.T or an artificial chemical synthesis method, and the like by using genetic engineering recombinant technology. When the recombinant technology is used, the heat-resistant agarase may be used by replacing a supernatant or supernate fluid of the transformed E. coli culture by transforming E. coli, but the method is not particularly limited thereto. According to a specific exemplary embodiment, the heat-resistant agarase may be obtained from E. coli transformed with a recombinant vector including the base sequence set forth in SEQ ID NO: 2, or a culture thereof.

(25) The heat-resistant agarase and agarose or agar may produce neoagarotetraose or neoagarohexaose by reacting at a pH of 5 to 9 under a condition of 0 to 300 rpm within a temperature range of 40 C. to 60 C. for 30 minutes to 7 days.

(26) The exo-type agarase is an enzyme which breaks down agarooligosaccharides into disaccharides neoagarobiose and agarotriose (D-galactose--1,4 linkage-3,6-anhydro-L-galactose--1,3 linkage-D-galactose), and an enzyme (hereinafter, also referred to as Aga50D) that cleaves a -1,4-glycosidic bond between D-galactose and 3,6-anhydro-L-galactose in agarose.

(27) For the exo-type agarase, not only the amino acid sequence set forth in SEQ ID NO: 3, but also a protein having the agarooligosaccharide hydrolytic activity as a variant protein with one or more substitutions, deletions, translocations, additions, and the like of the enzyme are included in the right scope of rights of the enzyme of the present invention, and preferably, the exo-type agarose may include the amino acid sequence set forth in SEQ ID: 3 and an amino acid sequence having a sequence identity of 80% or more, 85% or more, 90% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, and 99% or more with the sequence.

(28) The exo-type agarase may be derived from Saccharophagus degradans 2-40.sup.T, but is not particularly limited thereto.

(29) The exo-type agarase may be separated and purified from a supernatant of the Saccharophagus degradans 2-40.sup.T culture, and may be produced and separated by a strain other than the Saccharophagus degradans 2-40.sup.T or an artificial chemical synthesis method, and the like by using genetic engineering recombinant technology.

(30) When the recombinant technology is used, in order to facilitate typical recombinant protein expression, for example, it is possible to use factors such as an antibiotic resistance gene, and a reporter protein or peptide which may be used for affinity column chromatography, and the technology corresponds to a scope which the person skilled in the art to which the present invention pertains can easily carry out. For example, the exo-type agarase may be used as a replacement for a supernatant of the transformed yeast culture by transforming an edible strain, for example, yeast. For a more specific preparation technique, Korean Patent Application Laid-Open No. 2010-0040438 (Apr. 20, 2010) may be referenced.

(31) The reaction of the agarooligosaccharide with the exo-type agarase may be carried out within a temperature range of 20 to 40 C. for 30 minutes to 7 days. More specifically, the reaction may be carried out within a temperature range of 25 to 35 C. for 1 day to 4 days.

(32) For an -neoagarobiose hydrolase (also referred to as SdNABH) which may break down the neoagarobiose into 3,6-anhydro-L-galactose and D-galactose, not only the amino acid sequence set forth in SEQ ID NO: 4, but also a protein having the neoagarobiose hydrolytic activity as a variant protein with one or more substitutions, deletions, translocations, additions, and the like of the enzyme are included in the scope of rights of the enzyme of the present invention, and preferably, the -neoagarobiose hydrolase includes an amino acid sequence having a sequence identity of 80% or more, 85% or more, 90% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, and 99% or more with the amino acid sequence set forth in SEQ ID NO: 4.

(33) The -neoagarobiose hydrolase may be derived from Saccharophagus degradans 2-40.sup.T, but is not particularly limited thereto.

(34) The -neoagarobiose hydrolase may be separated and purified from a supernatant or supernate fluid of the Saccharophagus degradans 2-40.sup.T culture, and may be produced and separated by a strain other than the Saccharophagus degradans 2-40.sup.T or an artificial chemical synthesis method, and the like by using genetic engineering recombinant technology. For a more specific preparation technique, Korean Patent Application Laid-Open No. 2013-0085017 (Jul. 26, 2013) may be referenced.

(35) The reaction of the neoagarobiose with the -neoagarobiose hydrolase may be carried out within a temperature range of 20 to 40 C. for 30 minutes to 7 days. More specifically, the reaction may be carried out within a temperature range of 25 to 35 C. for 1 day to 4 days.

(36) For a breakdown product of the neoagarobiose, 3,6-anhydro-L-galactose at a high purity of approximately 95% may be separated and purified by sequentially carrying out silica gel chromatography which is adsorption chromatography and Bio-Gel P2 chromatography which is gel permeation chromatography.

(37) In the present specification, protein and polypeptide are used interchangeably.

(38) In the present invention, the fact that a polypeptide has a sequence identity of a specific ratio (for example, 80%, 85%, 90%, 95%, or 99%) with another sequence means that when the two sequences are aligned, the amino acid residues at the ratio are the same as each other at the time of comparing the sequences. The alignment and percentage homology or identity may be determined by using those described in any suitable software program publicly known in the art, for example, a document [CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (F. M. Ausubel et al., (eds) 1987 Supplement 30 section 7.7.18)]. Examples of a preferred program include a GCG Pileup program, FASTA (Pearson et al., 1988 Proc. Natl Acad. Sci USA 85:2444-2448), and BLAST (BLAST Manual, Altschul et al., Natl. Cent. Biotechnol. Inf., Natl Lib. Med. (NCIB NLM NIH), Bethesda, Md., and Altschul et al., 1997 NAR25:3389-3402). Another preferred alignment program is ALIGN Plus (Scientific and Educational Software, PA), and preferably, default parameters are used. Another available sequence software program is the TFASTA Data Searching Program available in the Sequence Software Package Version 6.0 (Genetics Computer Group, University of Wisconsin, Madison, Wis.).

(39) In the present invention, the term recombinant when used in connection with a cell, a nucleic acid, a protein, or a vector indicates that the cell, the nucleic acid, the protein, or the vector has been modified by introducing a heterologous nucleic acid or protein or changing an original nucleic acid or protein, or that the cell is derived from the thus modified cell. That is, for example, a recombinant cell expresses a gene which is not found within the original (non-recombinant) form of the cell, or otherwise, the recombinant cell expresses an original gene which is abnormally expressed or not expressed at all during expression.

(40) In the present specification, nucleic acid encompasses single stranded or double stranded DNA and RNA, and a chemical variant thereof. Nucleic acid and polynucleotide may be used interchangeably in the present application. Since the genetic code is degenerate, one or more codons may be used in order to encode a specific amino acid, and the present invention encompasses a polynucleotide encoding a specific amino acid sequence.

(41) The term introduction in which a nucleic acid sequence is inserted into a cell means transfection, or transformation or transduction, and a reference to the integration of a nucleic acid sequence into an eukaryotic cell or a prokaryotic cell is included, and in this case, the nucleic acid sequence is integrated into a genome (for example, a chromosome, a plasmid, a plastid, or a mitochondrial DNA) of a cell, and thus is converted into an autonomous replicon, or transiently expressed.

(42) Hereinafter, the present invention will be described in more detail through the Examples according to the present invention, but the scope of the present invention is not limited by the Examples suggested below.

<Example 1> Measurement of Sol-Gel Phase Transition of Agarose by Cooling

(43) In order to observe the temperature interval in which agarose in a solution state of being dissolved in water at a high temperature is changed into a gel state while decreasing the temperature, the sol-gel phase transition of agarose was measured by using specific optical rotation while cooling the agarose from 80 C. to 10 C. after 1% (w/v) agarose at the time of cooling was dissolved in a 20 mM Tris-HCl buffer (pH 7.0).

(44) As illustrated in FIG. 1, it could be confirmed that agarose was gelled at a temperature less than 35 C.

<Example 2> Cloning and Expression of Aga16B

(45) After an endo-type -agarase aga16B gene (Sde_1175: UniProt accession no. Q21112) from a marine bacterium Saccharophagus degradans 2-40 was introduced into E. coli by being cloned into a pET21a plasmid, an overexpressed Aga16B enzyme was purified and used in an enzymatic reaction.

(46) For this purpose, genomic DNA was purified by using a commercial DNA kit (Bioneer, Korea), and Aga16B was amplified by PCR. In this case, the primers were Aga16B-N, 5-AAA GGATCC ATGGCAGATTGGGACGGAATT-3 (Tm: 59.4)(SEQ ID NO: 5); and Aga16B-C, 5-AAA GCGGCCGC GTTGCTAAGCGTGAACTTATCTA-3 (Tm: 59.3)(SEQ ID NO: 6).

(47) The PCR product was a product in which a signal sequence positioned at amino acids 19-20 at the N-terminus of Aga16B was removed. BamHI and NotI were used as restriction enzymes, and were positioned at the 5 and 3 regions of the N- and C-terminal ends. The PCR product and pET21a were digested with BamHI and NotI, respectively, and ligated together using a T4 DNA ligase. And then, the resulting vector was transformed into BL21 E. coli.

(48) In order to produce recombinant proteins from each gene, the transformed E. coli was inoculated into a medium containing 50 m/mL of ampicillin, and grown at 37 C. When the transformed E. coli was grown until the mid-exponential phase, protein expression was induced at 16 C. for 16 hours after adding 0.1 mM isopropyl--D-thiogalactopyranoside (IPTG). Thereafter, the cells were harvested by centrifugation at 8,000 rpm for 20 minutes at 4 C., and then were resuspended in a lysis buffer (20 mM sodium phosphate and 500 mM sodium chloride, pH 7.4), and the cells were disrupted using a sonicator. The cells were centrifuged at 16,000 rpm for 1 hour at 4 C. After the protein was purified by using a His-Trap column (GE Healthcare) and concentrated by using an Amicon ultrafiltration membrane, the Aga16B protein was identified by SDS-PAGE. The concentration of Aga16B was measured using a BCA protein assay kit.

(49) As illustrated in FIG. 2, a band with a size of 63.7 kDa corresponding to Aga16B was identified.

<Example 3> Measurement of Activity, Optimal pH and Temperature of Aga16B

(50) A substrate was produced by dissolving 1% (w/v) agarose in 3 mL of a 20 mM Tris-HCl buffer (pH 7.0) in an autoclave at 121 C. for 10 minutes, and then 0.0625 mol of an Aga16B protein was added thereto, and the resulting mixture was allowed to react at 200 rpm for 30 minutes at 45 C.

(51) Further, the optimal reaction temperature and pH of Aga16B were monitored. For an optimal temperature experiment, a substrate was produced by putting 1% (w/v) agarose into a 20 mM Tris-HCl buffer (pH 7.0) and dissolving the agarose at 121 C. for 10 minutes, the Aga16B overexpressed in Example 2 was purified while cooling the substrate from 70 C. to 30 C. and was put into the substrate so as to be at a concentration of 4 mg/g agarose, and the resulting mixture was allowed to react at 200 rpm.

(52) For an optimal pH experiment, agarose was produced so as to be at a concentration of 1% (w/v) in each buffer by using a 20 mM sodium phosphate buffer (pH 5 to 7), a 20 mM Tris-HCl buffer (pH 7.5 to 9), and a 20 mH borate buffer (pH 9.5 to 11), and then a substrate was produced by dissolving the agarose in an autoclave at 121 C. for 10 minutes, an amount of protein, which is the same as that in the optimal temperature experiment, was added thereto, and the resulting mixture was allowed to react at 200 rpm for 30 minutes at 45 C.

(53) For all of the three experiments, after the protein was inactivated at 95 C. for 1 minute after a protein reaction, a supernatant was produced by centrifugation at 16,000 rpm for 10 minutes, the supernatant was mixed with a dinitrosalicylic acid (DNS) reagent at a ratio of 1:1, the resulting mixture was allowed to react at 95 C. for 5 minutes, and then a reducing sugar of a reaction product was measured by measuring an absorbance at 540 nm using a microplate reader. In this case, galactose was used as a standard material.

(54) As illustrated in FIG. 3a, the optimal pH of Aga16B was 7.5, but high activity was exhibited within a wide range from pH 5.5 to pH 8.5 similarly to the temperature. Further, as in FIG. 3b, it was shown that the enzyme had activity at a temperature of 40 C. or more where agarose is present in a sol (liquid) state, and the activity of the enzyme was shown to be high up to 60 C. In addition, the optimal temperature of the enzyme was shown to be 55 C., and high enzymatic activity was shown to be maintained within a wide range from 40 C. to 60 C.

<Example 4> Thermal Stability Experiment of Aga16B

(55) In order to carry out a thermal stability experiment of Aga16B, a substrate was produced by introducing a 20 mM Tris-HCl buffer (pH 7.0) and a 1% (w/v) agarose substrate and then dissolving using an autoclave at 121 C. for 10 minutes, and then the Aga16B protein was pre-incubated at 40 C., 45 C., 50 C., 55 C., 60 C., and 65 C., Aga16B was added thereto so as to be at a concentration of 4 mg/g agarose, and then a reducing sugar of a reaction product was measured through the DNS reaction by performing sampling at 0, 10, 20, 30, 60, 90, and 120 minutes while allowing the resulting mixture to react at 45 C. and 200 rpm.

(56) As illustrated in FIG. 4, it could be confirmed that the Aga16B was stable at 40 C., 45 C., and 50 C., and the enzymatic activity was decreased at 55 C. or more within 30 minutes by less than 20% as compared to the initial level, and as a result, the stability deteriorated.

<Example 5> Measurement of Suitable Aga16B Protein-Loading Amount

(57) Since a loading amount of an enzyme needs to be determined in order to apply the Aga16B protein to a process, an experiment of measuring a suitable loading amount was carried out.

(58) A suitable Aga16B-loading amount was measured under enzymatic reaction conditions of a 1% (w/v) agarose substrate, pH 7.0, and 45 C. and the initial reaction rates were compared by varying the Aga16B-loading amount.

(59) As illustrated in FIG. 5, the initial rate obtained by Aga16B increased until the enzyme loading of Aga16B was increased to 42 U/g agarose. Even though the amount of Aga16B loaded was increased to an Aga16B-loading amount higher than 42 U/g agarose, the initial rate of the enzymatic reaction was almost constantly maintained. As a result of the present experiment, the Aga16B loading at 42 U/g agarose was the same as that at 8 mg Aga16B/g agarose.

<Example 6> Effects of Metal Ions on Enzymatic Activity of Aga16B

(60) Effects of metal ions on the enzymatic activity of Aga16B were tested by selecting 0.1% (w/v) agarose as a substrate and one of various metal ions.

(61) As shown in Table 1, most ions did not affect the enzymatic activity of Aga16B, but CuCl.sub.2 and FeCl.sub.2 significantly decreased the enzymatic activity of Aga16B to 76.6% and 82.6% of the maximum activity, respectively.

(62) TABLE-US-00001 TABLE 1 Effects of Metal Ions on Relative Activity of Aga16B Metal salt Relative activity % Control.sup.a 100.0 0.3 CuCl.sub.2 76.6 0.6 MgCl.sub.2 99.1 0.1 MnCl.sub.2 93.4 0.5 CaCl.sub.2 96.5 0.2 FeCl.sub.2 82.6 0.7 NH.sub.4Cl 97.9 0.1 KCl 96.8 0.3 NaCl 93.0 0.3 .sup.aThe enzymatic activity when a metal ion was not present was set to 100%. The experimental value was expressed as average standard deviation obtained from triplicate experiments.

<Example 7> Kinetic Parameters of Aga16B

(63) In order to measure the kinetic parameters of Aga16B, an enzymatic reaction was performed at a pH of 7.0 and 45 C. in 3 mL of the entire reaction mixture volume including 0.04 mg/mL of purified Aga16B per concentration of agarose (0.5% to 2% (w/v)). The reaction time was 6 minutes for 0.5% and 1% (w/v) agarose and 10 minutes for 1.5% and 2% (w/v) agarose. The V.sub.max and K.sub.m were calculated from the Lineweaver-Burk plot. And then, these kinetic constants of Aga16B were compared with those of other -agarases belonging to GH16, that is, -agarases, originating from marine bacteria such as Streptomyces coelicolor, Microbulbifer elongatus JAMB-A7, and Agarivorans albus YKE-34.

(64) As shown in Table 2, the K.sub.m value of Aga16B with respect to agarose was 7.7 mg/ml, which was 38.5 times higher than that of AgaB34 and 3.5 times higher than that of DagA, respectively. The V.sub.max value of Aga16B was 18.3 U/mg proteins, which was 2.7 times lower than that of AgaB34. When compared to other -agarases belonging to GH16, Aga16B showed the lowest value of K.sub.cat (that is, 20 s.sup.1). Therefore, the catalytic efficiency (that is, K.sub.cat/K.sub.m) of Aga16B was relatively low as compared to those of other -agarases of GH16.

(65) TABLE-US-00002 TABLE 2 Comparison of the kinetic parameters of Aga16B with the known agarases belonging to GH16 V.sub.max (U/mg K.sub.m k.sub.cat k.sub.cat/K.sub.m Agarase Organism Substrate Product protein) (mg/mL) (s.sup.1) (s.sup.1/mg/mL) Reference Aga16B S. degradans Agarose DP4, 18.3 7.7 2.0 10.sup.1 2.6 10.sup.1 This 2-40.sup.T DP6 invention AgaB34 Agarivorans Agarose DP4 50.0 0.2 4.1 10.sup.1 2.1 10.sup.2 Fu et al. J albus Microbiol YKW- Biotechnol 34 19(3): 257-264, 2009 DagA Streptomyces Agarose DP4, 39.0 2.2 9.5 10.sup.3 4.3 10.sup.3 Temuujin coelicolor DP6 U et al. Appl Microbiol Biotechnol 92(4): 749-759, 2011 AgaA7 Microbulbifer Agar DP4 N.A. 3.0 2.9 10.sup.6 9.6 10.sup.5 Ohta et elongatus al. Appl JAMB- Microbiol A7 Biotechnol 64(4): 505-514, 2004 N.A.: not available

<Example 8> Product Analysis of Enzymatic Reaction Products of Aga16B

(66) In order to monitor the enzymatic reaction products of Aga16B, TLC and HPLC analyses were carried out. For the TLC, 1 l of the enzymatic reaction products was loaded onto a silica gel plate, eluted in a mobile phase in which n-butanol, ethanol, and water were mixed at a volume ratio of 3:1:1 (v/v/v), and then was color-developed by using 10% sulfuric acid and 0.2% 1,3-dihydroxynaphthalene. For the HPLC analysis, the reaction product samples obtained at a reaction time of 0, 2, 10, and 30 minutes were analyzed under a column temperature condition of 80 C. and at a flow rate of 0.5 mL/min by using a KS-802 column (Shodex).

(67) As illustrated in FIG. 6a, it could be confirmed that as a result of TLC, the reaction products were formed after a reaction time of 2 minutes, and as in FIG. 6b, it could be confirmed that through the HPLC analysis, the reaction products were neoagarotetraose and neoagarohexaose, which is DP4 and DP6, respectively. And, DP8 was detected as a minor product.

(68) In order to identify exact masses of the enzymatic reaction products by Aga16B, an MALDI-TOF/TOF MS analysis was performed. The MALDI-TOF/TOF MS is an ultrafleXtreme MALDI-TOF/TOF MS system (Bruker Daltonics, Bremen, Germany). The salts and buffer were removed by purifying the reaction products of Aga16B through solid-phase extraction using a porous graphitized carbon cartridge prior to the analysis (Thermo Fisher Scientific, San Jose, Calif., USA). The purified reaction products were re-dissolved in water, 1 L of the reaction products was spotted on a stainless steel target plate, and then 0.5 L of 0.1 mg/mL 2,5-dihydroxy-benzoic acid dissolved in 0.3 l of 0.01 M NaCl and 50% acetonitrile was spotted. A homogeneous crystal was formed by drying the spot under vacuum. The MALDI-TOF mass spectra were acquired in a positive mode over the m/z range from 500 to 3000 for a total of 2400 laser shots. To obtain MS/MS data, precursor ions were accelerated to 7.5 kV and selected in a time ion selector for fragment ion analysis in the TOF/TOF mode. Fragment ions generated by 1 keV collision energy via collision-induced dissociation (CID) of precursor ions were further accelerated by 19 kV in the LIFT cell, and their masses were analyzed after having them pass through the ion reflector. Argon was used as a collision gas at a pressure of 5.910.sup.6 mbar. Raw MS data and MS/MS data were processed using the flexAnalysis software (Version 3.3, Bruker Daltonics, Bremen, Germany)

(69) As illustrated in FIG. 7a, the exact masses of the main reaction products of Aga16B and agarose were measured as 653.2 and 959.3, respectively, which correspond to neoagarotetraose (DP4) and neoagarohexaose (DP6), respectively. Meanwhile, neoagarooctaose (DP8) with a mass of 1,265.4 was also detected as a minor product.

(70) Additionally, as a result of performing tandem MS for the analysis of the chemical structures of the main reaction products, neoagarotetraose and neoagarohexaose were confirmed, as illustrated in FIG. 7b and FIG. 7c. Specifically, the daughter ions produced from the precursor ions of neoagarotetraose and neoagarohexaose demonstrated that these reaction products consist of AHG and galactose, being bonded by alternating glycosidic bonds.

<Example 9> Experiment of Confirming Liquefaction of Agarose Broken Down by Aga16B

(71) To monitor the liquefaction degree of the reaction products by Aga16B, the absorbance for the agarose substrate, the Aga16B reaction products, and the 20 mM Tris-HCl buffer (pH 7.0) was measured.

(72) For this purpose, the absorbance was measured at 600 nm by using a product which caused the enzymatic reaction using a substrate in which 1% (w/v) agarose was dissolved in a 20 mM Tris-HCl buffer (pH 7.0) and an Aga16B protein and using a spectrophotometer, and the liquefaction degree was confirmed through the transparency. In this case, the substrate in which 1% (w/v) agarose was dissolved in a 20 mM Tris-HCl buffer (pH 7.0) was autoclaved at 121 C. for 10 minutes, and then cooled at room temperature, and the product obtained by allowing the Aga16B protein and the substrate to react with each other was a supernatant obtained by allowing the substrate in which 1% agarose dissolved in the 20 mM Tris-HCl buffer (pH 7.0) was autoclaved at 121 C. for 10 minutes to react with the protein at 45 C. for 30 minutes, and then inactivating the protein in boiling water at 95 C. or more, and performing centrifugation at 16,000 rpm for 10 minutes.

(73) As illustrated in FIG. 8, the 1% agarose was gelled, became opaque, and produced a high absorbance at 600 nm, and the Aga16B reaction product showed an absorbance at the same level as that of the 20 mM Tris-HCl. Through this, it was confirmed that Aga16B was obtained by enzymatically liquefying agarose.

<Example 10> Production of 3,6-Anhydro-L-Galactose Using Aga16B, Aga50D, and NABH

(74) In order to produce a monosaccharide by applying Aga16B to an enzymatic process, D-galactose and 3,6-anhydro-L-galactose were produced by using Aga16B, Aga50D and NABH enzymes.

(75) For this purpose, after 5% agarose was produced in 200 mL of a 20 mM Tris-HCl buffer (pH 7.0) and dissolved using an autoclave at 120 C. for 10 minutes, 19.7 mg of Aga16B was added thereto in order to break down agarose, the resulting mixture was allowed to react at 200 rpm for 12 hours at 55 C., and DP4 and DP6 were produced as the reaction products.

(76) In order to break down these reaction products, these reaction products were allowed to react with an exo-type disaccharide-producing enzyme, Aga50D (20 mg), at 25 C. and 200 rpm, and neoagarobiose was produced as a reaction product.

(77) After this reaction, SdNABH (10 mg) was allowed to react in order to produce D-galactose and 3,6-anhydro-L-galactose.

(78) Aga50D and SdNABH were prepared as described in Korean Patent Application Laid-Open No. 2010-0040438 (Apr. 20, 2010) and Korean Patent Application Laid-Open No. 2013-0085017 (Jul. 26, 2013), respectively, and used.

(79) The pattern of each reaction product was confirmed through HPLC analysis (FIG. 9).

<Example 11> Quantitative Analysis of 3,6-Anhydro-L-Galactose Through GC-MS Analysis

(80) The reaction product of SdNABH produced through Example 10 was analyzed by GC/MS and quantified. For this purpose, a derivatization process for the GC/MS analysis was performed. 20 L of the reaction product was dried with a Speed-Vac, and then 10 l of O-methylhydroxylamine hydrochloride in pyridine at a concentration of 4% (w/v) was added thereto, the resulting mixture was allowed to react at 30 C. for 90 minutes, 45 L of N-methyl-N-(trimethylsilyl) trifluoroacetamide was added thereto, and an analysis sample was prepared by allowing the resulting mixture to react at 37 C. for 30 minutes. For the instrument conditions for the GC/MS analysis, by using a DB5-MS capillary column, the column temperature was maintained at 100 C. for 3.5 minutes, and after the temperature was increased to 160 C., the temperature was maintained for 20 minutes. After the temperature was increased to 200 C., the temperature was maintained for 15 minutes, and finally, after the temperature was increased to 280 C., the temperature was maintained for 5 minutes. After 0.5 L of the sample was loaded, the sample was analyzed at 5 split ratios.

(81) As illustrated in Table 3, as a result of measuring the monosaccharide yield on the basis of the GC/MS quantitative result, a yield of 0.81 g/g agarose was obtained, which is a value corresponding to 72.5% of the maximum yield which may be theoretically obtained.

(82) TABLE-US-00003 TABLE 3 Production Yield of 3,6-Anhydro-L-Galactose Produced through Enzymatic Saccharification Enzymatic Enzymatic saccharification saccharification method using method using Tris-HCl buffer acetic acid pretreatment pretreatment and and Aga50D, Enzymatic Aga50D, ABG, ABG, and NABH saccharification and NABH (CH (CH Lee et al., method using Agarose Lee et al., (2015) (2015) Process Aga16B, saccharification Process Biochem Biochem Aga50D, and method 50: 1629-1633) 50: 1629-1633) NABH Saccharification 50.5 44.9 72.5 yield (% of theoretical maximum)

(83) The present invention may be applied to the field in which monosaccharides are produced from red algae.